Hepatitis C Virus (HCV)–Specific T Cell Responses in Injection Drug Users with Apparent Resistance to HCV Infection | Zendy

Prem Harichander Thurairajah | Zendy; Doha Hegazy | Zendy; Shilpa Chokshi | Zendy; Steve Shaw | Zendy; Andrew G. Demaine | Zendy; É. Kaminski | Zendy; Nikolai V. Naoumov | Zendy; Matthew Cramp | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Hepatitis C Virus (HCV)–Specific T Cell Responses in Injection Drug Users with Apparent Resistance to HCV Infection

Author(s) -

Prem Harichander Thurairajah,

Doha Hegazy,

Shilpa Chokshi,

Steve Shaw,

Andrew G. Demaine,

É. Kaminski,

Nikolai V. Naoumov,

Matthew Cramp

Publication year - 2008

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1086/593337

Subject(s) - hepatitis c virus , seroconversion , immunology , medicine , antibody , viremia , virology , hepatitis c , hepacivirus , flaviviridae , virus

Injection drug users (IDUs) are at risk of acquiring hepatitis C virus (HCV) infection. We have identified a cohort of long-term IDUs who remain uninfected by HCV despite high-risk behavior. We have categorized these subjects as "exposed uninfected" and have sought immunological correlates with this apparent resistance.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research